Skip to main content
. 2019 Apr;11(Suppl 6):S853–S863. doi: 10.21037/jtd.2018.10.37

Table 1. Patient demographics.

Patient Gender Age (years) INTERMACS Type of device LVEF (%) Cardiomyopathy Follow-up (days) Status
1 Female 60 III HA5 20 Non-ischemic 429 Alive, cardiac transplant
2 Male 55 III HA5 11 Ischemic 393 Deceased (intracranial bleeding)
3 Male 58 III HA5 15 Ischemic 458 Alive on LVAD
4 Male 70 III HA5 20 Non-ischemic 325 Alive on LVAD
5 Male 62 II HA5 20 Non-ischemic 217 LVAD exchange (pump thrombosis)
6 Male 61 III HA5 15 Ischemic 233 Alive on LVAD
7 Female 61 III aVAD 30 Non-ischemic 121 Alive on LVAD
8 Male 54 III aVAD 15 Non-ischemic 108 Alive on LVAD
9 Male 49 III aVAD 25 Non-ischemic 73 Alive on LVAD
10 Male 62 III aVAD 15 Ischemic 52 Alive on LVAD
11 Male 57 III aVAD 16 Non-ischemic 29 Alive on LVAD

Age, INTERMACS and LVEF are given at time of LVAD implantation. INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support Score; HA5, Heart Assist 5; LVEF, left ventricular ejection fraction.